转化医学合作的困境解析及对策  

Analysis and strategies on difficult position of translational medicine cooperation

作　　者：丁力[1] 贾兆宝 周玲君[1] 陈菲[1] 顾申[1] Ding Li Jia Zhaobao Zhou Lingjun Chen Fei Gu Shen.(Institute for Translational Medicine, Second Military Medical University, Shanghai 200433, P. R. Chin)

机构地区：[1]第二军医大学转化医学研究院,上海200433

出　　处：《中华医学科研管理杂志》2017年第1期21-22,30,共3页Chinese Journal of Medical Science Research Management

摘　　要：转化医学的主要目的是为了打破基础医学与临床医学、医药产业之间的固有屏障,建立直接而紧密的联系与合作.然而转化医学在世界范围内仍处于探索阶段,真正意义上的转化应用微乎其微.本文从合作资源、合作主体以及合作文化3个方面分析了转化医学合作的困境,提出应积极促进临床医学研究,推动分类评价和代表作评价机制,积极营造转化医学合作氛围,努力打破转化医学的合作困局.The main purposes of translational Medicine is to break the barrier among the basic medicine,clinical medicine and drug R＆amp;D in order to establish direct and close connection and cooperation between them.However,so far almost in the world wide,translational medicine is still at the exploration stage and far away from the real transformation.This article reviewed the difficult position of translational medicine cooperation from the three aspects of cooperative resources,sponsor and domestic culture,and then suggested to promote clinical medicine research,set up new assessment systems which focus on classified evaluation and representative work,as well as create the culture of cooperation.

关 键 词：转化医学 合作 困境 解析与对策 

分 类 号：R-05[医药卫生]